Skip to content

Clinical trials

Phase 2 Vitiligo trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vitiligo Phase: Phase 2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20121
20161
20172
20181
20191
20202
20213
20224
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Recruiting2
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
University of Colorado, Denver2
AbbVie1
Aclaris Therapeutics, Inc.1
Arcutis Biotherapeutics, Inc.1
Clinuvel, Inc.1
Dermavant Sciences GmbH1
Eli Lilly and Company1
Icahn School of Medicine at Mount Sinai1
John Harris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vitiligo23
Hypopigmentation2
Pigmentation Disorders2
Skin Diseases2
Alopecia Areata1
Autoimmune Diseases1
Cicatrix1
Cicatrix, Hypertrophic1
Dermatitis, Atopic1
Down Syndrome1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.